Effect of low-molecular weight trypsin inhibitor, nafamostat mesilate, on trypsin activity using the pancreatic acinar cells

Pancreas. 2009 Jul;38(5):595-7. doi: 10.1097/MPA.0b013e31819156de.
No abstract available

Publication types

  • Letter

MeSH terms

  • Animals
  • Aprotinin / pharmacology
  • Benzamidines
  • Cells, Cultured
  • Enzyme Activation / drug effects
  • Glycoproteins / deficiency
  • Glycoproteins / genetics
  • Guanidines / chemistry
  • Guanidines / pharmacology*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Molecular Weight
  • Pancreas / cytology
  • Pancreas / drug effects*
  • Pancreas / metabolism
  • Prostatic Secretory Proteins / genetics
  • Trypsin / metabolism*
  • Trypsin Inhibitor, Kazal Pancreatic
  • Trypsin Inhibitors / chemistry
  • Trypsin Inhibitors / pharmacology*
  • Trypsinogen / metabolism

Substances

  • Benzamidines
  • Glycoproteins
  • Guanidines
  • Prostatic Secretory Proteins
  • Spink1 protein, mouse
  • Trypsin Inhibitors
  • Trypsin Inhibitor, Kazal Pancreatic
  • Trypsinogen
  • Aprotinin
  • Trypsin
  • nafamostat